In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is presenting Spring 2020 events through online platforms and some of our previously scheduled events are being postponed to a later date. Please check our events listing for the latest information and contact our Customer Service team with any additional questions. For Academy programs and resources about COVID-19, click here.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.


The Amygdala in Brain Function

Edited by Edited by Patricia Shinnick-Gallagher (The University of Texas Medical Branch, Galveston, TX), Asla Pitkänen (University of Kuopio, Kuopio, Finland), and Anantha Shekhar (Indiana University Medical Center, Indianapolis, Indiana)
The Amygdala in Brain Function

Published: April 2003

Volume 985

Learn More

The amygdala is a brain area that has recently become one of the hottest topics in neuroscience. The papers in this volume provide information on the basic characteristics of amygdala function including neuroanatomical, electrophysiological, behavioral, and imaging studies in animals and humans. Papers also examine whether the amygdala is an integrator or repositor of memories; the role of the amygdala in withdrawal from drugs of abuse; and the amygdala's role in cardiovascular control, stress, and pain. This information is integrated with recent findings in clinical human diseases (Alzheimer's, epilepsy, anxiety, depression, schizophrenia, and panic disorder) in which the function of the amygdala is compromised. Pharmacological information is presented to provide a foundation for designing drugs for treatment of pathologic disorders of the amygdala.